March 9, 2020 — The American College of Cardiology (ACC) is offering updates on the clinical impact of novel coronavirus ...
ACC
This channel contains news about the American College of Cardiology (ACC), including coverage of its annual meeting and links to recently released practice guidelines. The ACC is a leading resource for cardiology professionals, including all its subspecialties.
March 09, 2020
March 9, 2020 — Less than week after the American College of Cardiology (ACC) said it would push ahead with holding its ...
March 09, 2020
October 8, 2019 — Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of ...
October 08, 2019Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
John Rumsfeld, M.D., Ph.D., FACC, American College Cardiology (ACC) chief innovation officer, and professor of medicine ...
June 20, 2019
April 18, 2019 — A recent study found patients with atherosclerotic cardiovascular disease cut their risk of a second ...
April 18, 2019
Sponsored Content | Videos | Information Technology
With Intellispace Enterprise Edition as the foundation, Philips Healthcare is connecting facilities and service areas ...
April 17, 2019Sponsored Content
Blog | Cardiac Diagnostics
The show floors at the American College of Cardiology (ACC) 2018 meeting in March and at the Heart Rhythm Society (HRS) ...
May 10, 2018
April 5, 2019 — Medical device startup HeartHero was the winner in the Innovation Challenge at the 2019 American College ...
April 05, 2019
April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut ...
April 03, 2019
March 29, 2019 — The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of ...
March 29, 2019
March 29, 2019 — Taking a high dose of icosapent ethyl significantly reduces the occurrence of first, subsequent and ...
March 29, 2019![New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) continued to deliver reductions in the heart failure biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity and prognosis.[1] The data was presented as a late-breaker at the American College of Cardiology (ACC) 2019 Annual Scientific Session in March.](/sites/default/files/styles/content_feed_medium/public/Entresto_bottles.jpg?itok=sp56E5GI)
March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril ...
March 27, 2019
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the annual ...
March 27, 2019
Khaldoun Tarakji, M.D., MPH, staff physician in the Section of Electrophysiology and Pacing in the Robert and Suzanne ...
March 26, 2019
March 26, 2019 — Level Ex, creators of medical video games for physicians, expanded into cardiology with the launch of ...
March 26, 2019
William Pinsky, M.D., a pediatric cardiologist and CEO of the Educational Commission for Foreign Medical Graduates ...
March 26, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now